131 related articles for article (PubMed ID: 10663670)
1. [Prognostic factors and survival in chronic myeloproliferative disorders].
Kvasnicka HM; Thiele J; Schmitt-Graeff A; Schaefer HE
Pathologe; 2000 Jan; 21(1):63-72. PubMed ID: 10663670
[TBL] [Abstract][Full Text] [Related]
2. [Chronic myeloproliferative disorders. The new WHO classification].
Thiele J; Kvasnicka HM
Pathologe; 2001 Nov; 22(6):429-43. PubMed ID: 11766643
[TBL] [Abstract][Full Text] [Related]
3. Diagnosis, pathogenesis and treatment of the myeloproliferative disorders essential thrombocythemia, polycythemia vera and essential megakaryocytic granulocytic metaplasia and myelofibrosis.
Michiels JJ; Kutti J; Stark P; Bazzan M; Gugliotta L; Marchioli R; Griesshammer M; van Genderen PJ; Brière J; Kiladjian JJ; Barbui T; Finazzi G; Berlin NI; Pearson TC; Green AC; Fruchtmann SM; Silver RT; Hansmann E; Wehmeier A; Lengfelder E; Landolfi R; Kvasnicka HM; Hasselbalch H; Cervantes F; Thiele J
Neth J Med; 1999 Feb; 54(2):46-62. PubMed ID: 10079679
[TBL] [Abstract][Full Text] [Related]
4. [Apoptosis and proliferation in the bone marrow of chronic myeloproliferative disorders--biological and prognostic importance].
Kvasnicka HM; Thiele J
Pathologe; 2000 Jan; 21(1):55-62. PubMed ID: 10663669
[TBL] [Abstract][Full Text] [Related]
5. [Histologic and hematological findings in CML. A comparative immunohistochemical-morphometric and clinical study on bone marrow biopsies from 604 patients derived from two institutes of pathology (Cologne/Freiburg)].
Thiele J; Kvasnicka HM; Schmitt-Graeff A; Schaefer HE
Pathologe; 2000 Jan; 21(1):39-54. PubMed ID: 10663668
[TBL] [Abstract][Full Text] [Related]
6. [Prognostic value of bone marrow biopsy in chronic myeloproliferative disorders].
Bettini R; Marzetta K; Miglioranza A; Redaelli S; Maino C; Maffiolini A; Gorini M
Recenti Prog Med; 2003; 94(7-8):314-20. PubMed ID: 12868237
[TBL] [Abstract][Full Text] [Related]
7. Clinicopathological diagnosis and differential criteria of thrombocythemias in various myeloproliferative disorders by histopathology, histochemistry and immunostaining from bone marrow biopsies.
Thiele J; Kvasnicka HM; Diehl V; Fischer R; Michiels J
Leuk Lymphoma; 1999 Apr; 33(3-4):207-18. PubMed ID: 10221501
[TBL] [Abstract][Full Text] [Related]
8. Histological features of prognostic significance in CML--an immunohistochemical and morphometric study (multivariate regression analysis) on trephine biopsies of the bone marrow.
Thiele J; Kvasnicka HM; Titius BR; Parpert U; Nebel R; Zankovich R; Dienemann D; Stein H; Diehl V; Fischer R
Ann Hematol; 1993 Jun; 66(6):291-302. PubMed ID: 8318559
[TBL] [Abstract][Full Text] [Related]
9. Hematopathologic findings in the myeloproliferative disorders.
Dickstein JI; Vardiman JW
Semin Oncol; 1995 Aug; 22(4):355-73. PubMed ID: 7638633
[TBL] [Abstract][Full Text] [Related]
10. Relevance of bone marrow features in the differential diagnosis between essential thrombocythemia and early stage idiopathic myelofibrosis.
Thiele J; Kvasnicka HM; Zankovich R; Diehl V
Haematologica; 2000 Nov; 85(11):1126-34. PubMed ID: 11064463
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of monocytosis in patients with myeloproliferative disorders.
Beran M; Shen Y; Onida F; Wen S; Kantarjian H; Estey E
Leuk Lymphoma; 2006 Mar; 47(3):417-23. PubMed ID: 16396764
[TBL] [Abstract][Full Text] [Related]
12. Histochemistry and morphometry on bone marrow biopsies in chronic myeloproliferative disorders - aids to diagnosis and classification.
Thiele J; Kvasnicka HM; Fischer R
Ann Hematol; 1999 Nov; 78(11):495-506. PubMed ID: 10602893
[TBL] [Abstract][Full Text] [Related]
13. Prognostic impact of bone marrow erythropoietic precursor cells and myelofibrosis at diagnosis of Ph1+ chronic myelogenous leukaemia--a multicentre study on 495 patients.
Kvasnicka HM; Thiele J; Schmitt-Graeff A; Diehl V; Zankovich R; Niederle N; Leder LD; Schaefer HE
Br J Haematol; 2001 Mar; 112(3):727-39. PubMed ID: 11260078
[TBL] [Abstract][Full Text] [Related]
14. CD34+ stem cells in chronic myeloproliferative disorders.
Thiele J; Kvasnicka HM
Histol Histopathol; 2002 Apr; 17(2):507-21. PubMed ID: 11962756
[TBL] [Abstract][Full Text] [Related]
15. Bone marrow angiogenesis: methods of quantification and changes evolving in chronic myeloproliferative disorders.
Kvasnicka HM; Thiele J
Histol Histopathol; 2004 Oct; 19(4):1245-60. PubMed ID: 15375769
[TBL] [Abstract][Full Text] [Related]
16. A histomorphometric analysis of trephine biopsies of bone marrow from 65 patients with chronic myeloid leukemia. Classification of patients into subgroups with different survival patterns.
Thiele J; Wienhold S; Zankovich R; Fischer R
Anal Quant Cytol Histol; 1990 Apr; 12(2):103-16. PubMed ID: 2350386
[TBL] [Abstract][Full Text] [Related]
17. Potential of bone marrow biopsy in chronic myeloproliferative disorders (MPD).
Bartl R; Frisch B; Wilmanns W
Eur J Haematol; 1993 Jan; 50(1):41-52. PubMed ID: 8436214
[TBL] [Abstract][Full Text] [Related]
18. Clinical and pathological criteria for the diagnosis of essential thrombocythemia, polycythemia vera, and idiopathic myelofibrosis (agnogenic myeloid metaplasia).
Michiels JJ; Thiele J
Int J Hematol; 2002 Aug; 76(2):133-45. PubMed ID: 12215011
[TBL] [Abstract][Full Text] [Related]
19. A critical reappraisal of the WHO classification of the chronic myeloproliferative disorders.
Thiele J; Kvasnicka HM
Leuk Lymphoma; 2006 Mar; 47(3):381-96. PubMed ID: 16396760
[TBL] [Abstract][Full Text] [Related]
20. Evidence from molecular genetic and cytogenetic analyses that bone marrow histopathology is reliable in the diagnosis of chronic myeloproliferative disorders.
Werner M; Kaloutsi V; Kausche F; Buhr T; Georgii A
Virchows Arch B Cell Pathol Incl Mol Pathol; 1993; 63(4):199-204. PubMed ID: 8099457
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
